Meier B, Friedli B, von Segesser L
Hôpital Cantonal Universitaire de Genève.
Herz. 1988 Feb;13(1):1-13.
The experimental and early clinical experience with percutaneous valvuloplasty using trefoil and bifoil balloon catheters (Schneider Shiley) and a long introducer sheath with a new back-up wire are reported. The trefoil balloon consists of three and the bifoil balloon of two angioplasty balloons mounted in parallel on a single catheter. Inflated, they form a rosette allowing for some blood flow through the spaces between the individual balloons. These small balloons are more pressure tolerant than one large balloon. The hemodynamic advantage of these balloons compared to single balloons could be demonstrated in animal experiments (healthy valves and surgically created stenoses). In 31 consecutive patients with trefoil-bifoil balloon valvuloplasty, there was no inhospital mortality. The results of trefoil valvuloplasty in twelve patients with pulmonary stenosis compared favorably to those of patients treated with single balloons. There were no technical failures or complications. There were two unsatisfactory results (severely dysplastic valve). In the aortic valve, the results with calcified stenoses were satisfactory at first but disappointing during follow-up. There were no technical failures but one of nine patients suffered an embolic myocardial infarction. In the mitral valve, there were two failures (one deficient equipment, one stroke during balloon positioning). In one case, insufficient balloon size led to an inadequate result. One patient needed surgical drainage for a pericardial tamponade. In two patients, mitral regurgitation was significantly increased. A 17F long sheath was developed to further facilitate balloon valvuloplasty. It guides the balloon catheter across the valve (and across the septum in case of the mitral valve), stabilizes it during inflation, and serves as a second pressure line to continuously monitor the transvalvular pressure gradient. It prevents bleeding at the puncture site during the intervention and presumably reduces the trauma to the artery. Because of its thrombogenic potential, heparinization of the patients is essential. The largest balloon accepted by the sheath is a 2 X 19 bifoil balloon which was the reason to use a bifoil balloon in some mitral valves. Trefoil balloons put in place through a long sheath provide some theoretical advantages over conventional single balloons introduced over guidewires that need to be evaluated by larger clinical studies. Although they do not prevent circulatory collapse during initial inflation in tight stenoses, they permit transvalvular flow when fully unfolded.
本文报道了使用三叶形和双叶形球囊导管(施奈德·希利公司)以及带有新型支撑导丝的长导入鞘进行经皮瓣膜成形术的实验和早期临床经验。三叶形球囊由三个血管成形球囊组成,双叶形球囊由两个血管成形球囊平行安装在一根导管上。充气后,它们形成一个玫瑰花结,使一些血流能够通过各个球囊之间的间隙。这些小球囊比一个大球囊更耐压。与单个球囊相比,这些球囊在动物实验(健康瓣膜和手术造成的狭窄)中展现出了血流动力学优势。在连续31例接受三叶形 - 双叶形球囊瓣膜成形术的患者中,无院内死亡病例。12例肺动脉狭窄患者接受三叶形瓣膜成形术的结果优于接受单个球囊治疗的患者。无技术失败或并发症发生。有2例结果不理想(瓣膜严重发育异常)。在主动脉瓣方面,钙化狭窄患者最初的结果令人满意,但随访期间令人失望。无技术失败,但9例患者中有1例发生栓塞性心肌梗死。在二尖瓣方面,有2例失败(1例设备不足,1例在球囊定位时发生中风)。有1例因球囊尺寸不足导致结果不理想。1例患者因心包填塞需要手术引流。2例患者二尖瓣反流显著增加。研发了一种17F长鞘以进一步方便球囊瓣膜成形术。它引导球囊导管穿过瓣膜(二尖瓣时穿过间隔),在充气时使其稳定,并作为第二条压力线持续监测跨瓣膜压力梯度。它可防止介入过程中穿刺部位出血,并可能减少对动脉的创伤。由于其具有血栓形成的潜在风险,患者进行肝素化至关重要。该鞘所能容纳的最大球囊是2×19双叶形球囊,这也是在一些二尖瓣中使用双叶形球囊的原因。通过长鞘置入的三叶形球囊相较于通过导丝引入的传统单个球囊具有一些理论优势,这需要通过更大规模的临床研究来评估。尽管它们在严重狭窄初始充气时不能防止循环衰竭,但在完全展开时允许跨瓣膜血流。